• 出版社/出版日：Mordor Intelligence / 2018年5月1日
|Single User（1名様用）||￥565,250 (USD4,250)||▷ お問い合わせ|
|Team User（7名様用）||￥598,500 (USD4,500)||▷ お問い合わせ|
|Corporate User||￥1,163,750 (USD8,750)||▷ お問い合わせ|
The global medical device technologies market is expected to register a CAGR of 7% during the forecast period of 2018–2023. Medical device manufacturing is a long process requiring robust SOPs and strict guidelines to be followed. Nowadays, the design and production have become easier with the help of new modeling platforms. The new devices are dedicated to a consumer-driven model that includes wearable devices, wireless internet linked systems, etc. Technologies, such as RFID and motion sensing are being used in monitoring devices. The medical device companies are searching for ways of implementing technology by understanding the needs of the customers and ensuring that the devices work round the clock.
Rise in Number of Chronic Diseases
Globally, the disease burden is shifting from infectious diseases to chronic conditions, with a corresponding escalation in incidence rates of cancer. Chronic diseases, such as heart disease, cancer, diabetes, stroke, and arthritis are long lasting in their effects. Cancer and cardiovascular diseases are the two most common causes of mortality. Globally, chronic diseases kill more than 38 million people each year. Cardiovascular diseases account for most of the chronic diseases related deaths (17.5 million people annually), followed by cancers (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million). These four groups account for 82% of all chronic disorder deaths. The rise in incidences of chronic diseases has increased the demand for medical devices. The other factors such as investment in R&D and the need for preventive healthcare are driving the medical device technologies market.
Strict FDA Regulations
Strict FDA regulations are bound to be present in the field of healthcare. The regulatory framework for medical devices is not standardized in many countries across the globe. FDA’s Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who design, manufacture, repackage, relabel, and import medical devices into the United States. In addition, CDRH regulates radiation-emitting electronic products, such as lasers, X-ray systems and ultrasound equipment. The Food and Drug Administration (FDA) strictly regulates the approval of medical devices depending on their class. Class I devices can be self-registered, but class II devices require a premarket notification, i.e., 510(k) submission to FDA to demonstrate that the device to be marketed is as safe and effective as a legally marketed device. Whereas, approval for the class III device, i.e., premarket approval (PMA) is the most stringent type of device marketing application that is required by the FDA.
FDA has strict regulations to approve marketing devices, due of which many manufactures prefer outsourcing their devices to other countries. The rules also pose several barriers to technological innovation, which might hamper the improvement of prevention, diagnosis, and treatment of disease. When the FDA delays the approval process, companies lose profits. New medical device technologies need more time to be tested, as the FDA is responsible for the safety and reduction of risks to a minimum. The strict FDA regulations are hindering the growth of the medical device technologies market. The other factors such as uncertainty in reimbursement and increase in the cost of services are also hindering the growth of the market.
United States Leads the Market in North America
In 2017, the United States medical device technologies market held the largest market share in the North America region due to the presence of a large number of companies located in the country. R&D investment in the companies has increased drastically, which has, in turn, led to the invention of new technologies.
Key Developments in the Market
• December 2017: Siemens Healthineers announced the acquisition of Fast Track Diagnostics.
• July 2017: Cardinal Health acquired Medtronic’s Patient Recovery Business.
Major Players: GE HEALTHCARE, SIEMENS HEALTHINEERS, MEDTRONIC, JOHNSON & JOHNSON, PHILIPS HEALTHCARE, BAXTER INTERNATIONAL, INC., CARDINAL HEALTH, INC., DANAHER CORPORATION, STRYKER CORPORATION, and 3M COMPANY, among others.
Reasons to Purchase the Report
• Follow the current and future global medical device technologies market in the developed and emerging markets.
• Examining the various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.レポート目次
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1.1 Rise in the Number of Chronic Diseases
6.1.2 Investment in Research & Development
6.1.3 Need for Preventive Healthcare
6.2.1 Strict FDA Regulations
6.2.2 Uncertainty in Reimbursement
6.2.3 Increase in the Cost of Services
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 Mobility-assisted Technology
220.127.116.11 Electronic Wheelchairs
18.104.22.168 Manual Wheelchairs
22.214.171.124 Ophthalmology Bio-implants
126.96.36.199 Cardio-vascular Bio-implants
188.8.131.52 Dental Bio-implants
184.108.40.206 Orthopedic Bio-implants
7.1.3 Diagnostic Imaging
220.127.116.11 Nuclear Imaging
18.104.22.168 Tomography Imaging
22.214.171.124 Mammography Imaging
126.96.36.199 Ultrasound Imaging
188.8.131.52 Protein Chips
184.108.40.206 DNA Chips
7.1.5 Minimally Invasive & Noninvasive Surgery
220.127.116.11 Laparoscopic Devices
18.104.22.168 Electronically Assisted Devices
7.1.7 Mobile Health and Telemedicine
22.214.171.124 Teletrauma Care
7.1.8 Molecular Diagnostics
7.1.9 Drug Discovery and Drug Delivery Devices
126.96.36.199 Infusion Devices
188.8.131.52 Injection-free Devices
7.2 By End Users
7.2.2 Diagnostic Centers
7.3 By Geography
7.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 Australia & New Zealand
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
7.3.4 Middle East & Africa
184.108.40.206 South Africa
220.127.116.11 Rest of the Middle East & Africa
7.3.5 South America
18.104.22.168 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 3M Company
9.2 Baxter International, Inc.
9.3 Cardinal Health, Inc.
9.4 Danaher Corporation
9.5 GE Healthcare
9.6 Johnson & Johnson
9.8 Philips Healthcare
9.9 Siemens Healthineers
9.10 Stryker Corporation
*List not Exhaustive
10. Future of the Market